{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PYC.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PYC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYC.AU\",,,,,undefined,":{"symbol":"PYC.AU","market":"AU","secType":"STK","nameCN":"PYC THERAPEUTICS LTD","latestPrice":1.24,"timestamp":1746079920000,"preClose":1.175,"halted":0,"volume":513068,"delay":0,"nameEN":"PYC THERAPEUTICS LTD","floatShares":315767380,"shares":583260447,"eps":-0.110129,"marketStatus":"Not Yet Opened","change":0.065,"latestTime":"05-01 16:12:00 AEST","open":1.2,"high":1.24,"low":1.17,"amount":615046,"amplitude":0.059574,"askPrice":1.24,"askSize":23440,"bidPrice":1.21,"bidSize":26000,"shortable":3,"etf":0,"ttmEps":-0.110129,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.175,"openAndCloseTimeList":[[1746057600000,1746079200000]],"volumeRatio":2.1488391094771737,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PYC.AU\",,,,,undefined,":{"symbol":"PYC.AU","floatShares":315767380,"roa":"-58.01%","roe":"-112.79%","lyrEps":-0.095849,"volumeRatio":2.1488391094771737,"shares":583260447,"dividePrice":0,"high":1.24,"amplitude":0.059574,"preClose":1.175,"low":1.17,"week52Low":0.9,"pbRate":"13.05","psRate":"28.94","week52High":2.1,"institutionHeld":0,"latestPrice":1.24,"committee":0.05178,"eps":-0.110129,"divideRate":0,"volume":513068,"delay":0,"ttmEps":-0.110129,"open":1.2,"prevYearClose":1.32,"prevWeekClose":1.115,"prevMonthClose":1.175,"prevQuarterClose":1.22,"fiveDayClose":1.03,"twentyDayClose":1.22,"sixtyDayClose":1.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PYC.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2481561881","title":"PYC Therapeutics to move to final stage of child blindness study","url":"https://stock-news.laohu8.com/highlight/detail?id=2481561881","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481561881?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:52","pubTimestamp":1730760720,"startTime":"0","endTime":"0","summary":"PYC Therapeutics  has has been approved to escalate doses of its drug candidate VP-001, treating Retinitis Pigmentosa 11, in a second patient cohort. Dosages will be lifted to 75 micrograms .The second cohort comprises patients part of the company’s Multiple Ascending Dose  study which runs alongside a Single Ascending Dose  study. Both Phase 1/2 studies are ongoing.A safety review body ticked off on higher doses for the MAD group on Tuesday.PYC reports that patients already doses with VP-001 in either stage of studies so far have shown “disease progression arrested and improved vision.”Members of the SAD cohort have already taken 75mcg doses with no adverse effects, PYC reported on Tuesday. Higher doses in the MAD group will ultimately allow PYC to collect more data to present to regulators.To that end, the company will approach the US FDA in an attempt to win research fast-track status for its drug once data from the ongoing studies is back with the company which is set for Q1 of nex","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/pyc-therapeutics-to-move-to-final-stage-of-child-blindness-study-2024-11-05/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["PYC.AU","BK7064","BK7067","LENZ","MAD.AU","BK4139"],"gpt_icon":0},{"id":"2481956573","title":"PYC Therapeutics Ltd-Rp11 Src Approves Dose Escalation to Final Patient Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2481956573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481956573?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:25","pubTimestamp":1730759141,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUE1TW28H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PYC.AU","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PYC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-15","symbol":"PYC.AU","defaultRemindTime":1731625200000,"type":"split","dateTimestamp":1731589200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"AU","date":"2024-03-18","symbol":"PYC.AU","defaultRemindTime":1710716400000,"type":"split","dateTimestamp":1710680400000,"forFactor":988235,"toFactor":1000000,"ratio":0.988235}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PYC.AU\",market:\"AU\",,,undefined,":[]}}